Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-04-11

FDA Approved: GABAPENTIN — Supplemental Application (Exelan Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for gabapentin submitted by Exelan Pharmaceuticals, Inc. This action confirms an approved supplemental submission (A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)